Therapeuticsmd Stock News

In the latest trading session, 3.25 million TherapeuticsMD Inc. (NASDAQ:TXMD) shares changed hands as the companys beta touched 1.78. With the companys most recent per share price at $0.60 changed hands at -$0.03 or -4.48% at last look, the market valuation stands at $279.79M. TXMDs current price is a discount, trading about -358.33% off its TherapeuticsMD Inc. (NASDAQ: TXMD): Why Investors Shouldnt Ditch TXMD Stock In 2021 Read More »

TherapeuticsMD, Inc. (TXMD) CEO Rob Finizio on Q3 2021 Earnings Conference Call - Earnings Call Transcript

TherapeuticsMD (NASDAQ:TXMD) reported its Q3 earnings results on Thursday, November 11, 2021 at 08:00 AM. Here's what investors need to know about the announcement.

Are these Webull penny stocks to buy or avoid right now? The post 5 Penny Stocks To Buy For Under $1 On Webull Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStock

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD) (“TXMD” or the “Company”), an innovative, leading women's healthcare company, today announced that it will report its thi

Despite having an impressive product portfolio and established commercial organization, the company has struggled to get their products off the launchpad and through COVID-19 headwinds.

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced the appointment of Mark Glickman as the Company's Chief Busin

LONDON--(BUSINESS WIRE)--Theramex launches Bijuva® (estradiol and progesterone), the first and only body-identical combined hormone therapy treatment for post-menopausal women

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced that the Centers for Medicare and Medicaid Services (CMS) con

When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their ove

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women's healthcare company, today announced the appointment of Hugh O'Dowd as President. Mr. O'Dowd succe

TherapeuticsMD's (TXMD) CEO Rob Finizio on Q2 2021 Results - Earnings Call Transcript

TherapeuticsMD (TXMD) delivered earnings and revenue surprises of 0.00% and 1.64%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?

Shares of TherapeuticsMD (NASDAQ:TXMD) moved higher by 4.1% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share were up 42.11% year over year to ($0.11),

BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (“TXMD” or the “Company”) (NASDAQ: TXMD), an innovative, leading women's healthcare company, today reported financial results for the se